AiCuris Compassionate Use Program (CUP, Germany) for an immunocompromised patient with treatment resistant Herpes Simplex Viris type 1 or 2 to be treated with Pritelivir 100 mg film-coated Tablets

Immunogenicity of repeated COVID-19 vaccination in patients post autologous stem cell transplantation (AUTO-COVID-VACC)

A Phase 2, Comparative, Randomised, Adaptive Trial to Evaluate the safety and immunogenicity of one dose of COMIRNATY in subjects that had received one dose of VAXZEVRIA (CombiVacS)

Expanded Access Programm Fosmanogepix (APX001-901 EAP)

EPICOVIDEHA - Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey

VACCELERATE - An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a 4th homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2 (BOOSTAVAC)

Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus specie (OASIS)

FungiScope - A Global Rare Fungal Infection Registry

Physiological effect of Glp-1 receptor activation on reward and effort learning in obesity

Assessment of Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age by a Multipathogen Antigen-Based Rapid Test-Kit (MAK-5-50+)

Analysis of pathophysiology and pathology of coronavirus disease 2019 (COVID-19), including chronic morbidity (NAPKON HAP)

Bloodstream Infection due to Multidrug-Resistant and -Susceptible Organisms Multicenter Study -Prognostic scores in patients with bloodstream Infection (BLOOMY-PREDICT)

A Phase 3, Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echinocandin followed by Oral Fluconazole (MARIO)

A Phase 3 Randomized, Double-blind, Active Comparator-controlled, Clinical Study to Evaluate the Safety, Tolerability, an Immunogenicity of V116 in Pneumococcal Vaccine-naive Adults 50 Years of Age or Older (V116-010)

VACCELERATE - Volunteer Registry Database for studies against SARS-CoV-2 and other infectious agents